Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 37   

Articles published

GSK 1,640.77 -6.73 (-0.41%)
price chart
Glaxo Diabetes Drug Data Revealed Amid Hostile Takeover
GlaxoSmithKline Plc will reveal detailed results today on an experimental treatment for diabetes that's part of the reason for a $2.6 billion hostile takeover bid for Human Genome Sciences Inc., its partner on the drug.
Glaxo to Begin Hostile Offer for Human Genome Sciences
Glaxo's bid is part of a wave of takeover activity in the pharmaceutical industry as drugmakers seek new products. Roche Holding AG made a hostile offer for Illumina Inc. in January, and abandoned it last month.
Glaxo's Stiefel Unit Loses $1.5 Million Verdict on Buybacks
Stiefel Laboratories lost a $1.5 million jury verdict to a former employee who claimed the company bought back his stock at artificially low prices before its acquisition in 2009 by GlaxoSmithKline Plc. Timothy Finnerty won the judgment on May 16 in ...
Human Genome in Talks With Potential Suitors
Human Genome Sciences Inc. said it's in talks with “major” pharmaceutical and biotechnology companies about a potential transaction and adopted measures to avoid a hostile takeover by GlaxoSmithKline Plc. Human Genome entered into confidentiality ...
Glaxo Scientist, Surgeon Targeting Historic British Hockey Gold
MacLeod, 27, also worked for GlaxoSmithKline Plc, the U.K.'s biggest drugmaker, as a sports scientist on its Lucozade energy drink.
Gates Foundation Veteran Yamada Retools Drugmaker Takeda
Tadataka “Tachi” Yamada led global health programs for Bill and Melinda Gates, oversaw GlaxoSmithKline Plc's research, was head physician at the University of Michigan and wrote gastroenterology textbooks.
Stopping Fake Drugs From Pakistan Is Too Late for Victims
More than 2,500 stalls wedged along dirt lanes in Karachi's busiest trading district offer everything from Pfizer Inc.'s cholesterol pill Lipitor to GlaxoSmithKline Plc's painkiller Panadol. Closer study of the remedies lining rickety shelves reveals ...
Google's Brin Makes Strides in Hunt for Parkinson's Cure
The advances are encouraging Pfizer Inc. and GlaxoSmithKline Plc to pursue a new class of medicines that may become the first to slow the progress of Parkinson's disease in a unique collaboration that Brin is funding.
Indian Drug Regulator Accused of Corruption and Collusion
The Central Drugs Standard Control Organization which oversees clinical trials and India's 10,000 drugmakers, approved medicines from companies including Novartis AG, GlaxoSmithKline Plc and Mumbai-based Cipla Ltd. without clinical trials required to ...
Hepatitis B Therapeutics - Pipeline Assessment and Market Forecasts to 2019
... the Future Market 707.2 Future Market Competition Scenario 708 Hepatitis B Therapeutics - Future Players 728.1 Introduction 728.2 Company Profiles 728.2.1 Bristol-Myers Squibb Company 728.2.2 Gilead Sciences 748.2.3 GlaxoSmithKline Plc 758.2.4 F.